大伙儿帮帮忙，求文献，谢谢

如来的观音

1.Committed neural progenitor cells derived from genetically modified bone marrow stromal cells ameliorate deficits in a rat model of stroke.
# T& T& p- [: H  ?4 t( \' Y7 nHayase M, Kitada M, Wakao S, Itokazu Y, Nozaki K, Hashimoto N, Takagi Y, Dezawa M.
( G+ Y( X; m$ u; \8 R" M$ Y, k2 R' iJCereb Blood Flow Metab. 2009 Aug;29(8):1409-20. Epub 2009 May 13.9 j0 s. q6 ]9 W! B4 V0 _3 f# k
0 k8 Y& p: u4 `" L  J* X  g
2.Reversal of dopaminergic degeneration in a parkinsonian rat following micrografting of human bone marrow-derived neural progenitors.  ?( o& i5 e5 ^
Glavaski-Joksimovic A, Virag T, Chang QA, West NC, Mangatu TA, McGrogan MP, Dugich-Djordjevic M, Bohn MC.
5 \' K5 Z4 w( @) dCell Transplant. 2009;18(7):801-14. Epub 2009 Sep 28.
  Z7 P3 `0 y9 S$ ^  t) `
. w; k3 P$ `5 d# R3.Glial cell line-derived neurotrophic factor-secreting genetically modified human bone marrow-derived mesenchymal stem cells promote recovery in a rat model of Parkinson's disease.
; O) y+ O: h% Z" s) k5 A$ k* FGlavaski-Joksimovic A, Virag T, Mangatu TA, McGrogan M, Wang XS, Bohn MC.  p* `5 \5 k# V+ b) D3 z# U; ^
J Neurosci Res. 2010 Sep;88(12):2669-81.